Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ: MIRM · Real-Time Price · USD
95.01
+1.01 (1.07%)
Jun 11, 2026, 9:46 AM EDT - Market open

Mirum Pharmaceuticals Analyst Ratings

Ratings History

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Morgan Stanley
Morgan Stanley
Buy
Maintains
$140$150
BuyMaintains$140$150+57.88%Jun 11, 2026
Citi
Citi
Buy
Initiates
$145
BuyInitiates$145+52.62%Jun 2, 2026
H.C. Wainwright
H.C. Wainwright
Buy
Reiterates
$185
BuyReiterates$185+94.72%Jun 1, 2026
Unknown Analyst
J.P. Morgan
No rating
J.P. Morgan
Buy
Initiates
$115
BuyInitiates$115+21.04%May 20, 2026
Wolfe Research
Wolfe Research
Buy
Initiates
$145
BuyInitiates$145+52.62%May 19, 2026
Leerink Partners
Leerink Partners
Buy
Maintains
$150$154
BuyMaintains$150$154+62.09%May 15, 2026
Raymond James
Raymond James
Buy
Maintains
$164$165
BuyMaintains$164$165+73.67%May 7, 2026
Robert W. Baird
Robert W. Baird
Buy
Maintains
$112$129
BuyMaintains$112$129+35.78%May 7, 2026

Upgrade to Pro

Get stock forecasts from Wall Street's highest rated professionals

Get much more with Stock Analysis Pro

  • Investment ideas from the top Wall Street analysts
  • Unlimited access to all data and tools
  • Advanced analyst filtering and sorting options
  • Up to 3 years of analyst rating history
Sign Up Today

Analyst Star Rankings

Our analyst star rankings are based on these four factors

Success Rate
The percentage of ratings that are profitable.
Average Return
The average percentage return within one year of the rating.
Rating Count
The more ratings the analyst has provided, the higher the score.
Recency
Ratings provided within the past year contribute to a higher score.